Under the leadership of Ramon Parsons, MD, PhD our cancer programs strive to translate preclinical innovations into future therapies with the goal of furthering the detection, treatment, and prevention of cancer.
NCI Supported Programs
The goal of the Cancer Immunology Program is to identify mechanisms underlying the suppression of effective anti-tumor immunity that could instruct the development of novel and impactful immunotherapies.
The main goal of the Cancer Mechanisms Program is to facilitate basic research that is pertinent to improving the diagnosis, treatment, and prevention of cancer.
Cancer Prevention and Control
The mission of the Cancer Prevention and Control Program is to reduce the burden of cancer incidence and mortality and improve the lives of cancer patients in our community.
The Liver Cancer Program is a comprehensive multidisciplinary program that incorporates all aspects of the disease from community screening to fundamental mechanisms of heptocarcinogenesis in both hepatocellular carcinoma (HCC) and intrahepatic cholangiocarcinoma (ICC).
Program in Development
Cancer Clinical Investigation
The goal of the Cancer Clinical Investigation Program is to develop new treatments and improve existing ones to better the lives of cancer patients.
Center for Computational Immunology
The Center for Computational Immunology is a hub for collaboration among researchers studying cancer, genomics, machine learning, and immunology, with the goal of developing optimal targeted immunotherapies for patients and increasing the number of patients who benefit from immunotherapy drugs that kill cancer.
The TCI Developmental Fund Awards specifically support translational and/or epidemiological projects that are in collaboration between TCI members.